Skip to content

Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.

Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00177632
Enrollment
66
Registered
2005-09-15
Start date
2003-07-31
Completion date
2004-07-31
Last updated
2005-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Weight Loss

Brief summary

The purpose is to examine the additional effect of either yoga or resistance exercise on weight loss weight combined with a standard behavioral weight loss intervention.

Interventions

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Female 2. 25-55 years of age 3. BMI = 25-35 kg/m2 4. Ability to provide informed consent. 5. Ability to provide consent from their personal physician to participate in this study.

Exclusion criteria

1. Participation in regular exercise (aerobic, yoga or resistance exercise) for \> 20 minutes per day on \> 2 days per week for the last 3 months. (This study is designed to recruit relatively sedentary adults.) 2. Currently being treated for psychological disorders/conditions and/or currently taking psychotropic medication. 3. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism. 4. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, pregnancy status will also be verified by the pregnancy test that is required for the baseline, 6 and 12 month DEXA). 5. Non-medicated resting systolic blood pressure \>160 mmHg or non-medicated resting diastolic blood pressure \>100 mmHg, or taking medication that would affect blood pressure. 6. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade). 7. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated. 8. History of myocardial infarction or valvular disease. 9. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).

Design outcomes

Primary

MeasureTime frame
weight loss

Secondary

MeasureTime frame
fitness
physical activity
dietary intake
mediators

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026